Correlation Between Acticor Biotech and Rubis SCA

Can any of the company-specific risk be diversified away by investing in both Acticor Biotech and Rubis SCA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acticor Biotech and Rubis SCA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acticor Biotech SAS and Rubis SCA, you can compare the effects of market volatilities on Acticor Biotech and Rubis SCA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acticor Biotech with a short position of Rubis SCA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acticor Biotech and Rubis SCA.

Diversification Opportunities for Acticor Biotech and Rubis SCA

0.24

Correlation Coefficient

Acticor Biotech  Rubis SCA

Modest diversification

The 3 months correlation between Acticor and Rubis is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Acticor Biotech SAS and Rubis SCA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rubis SCA and Acticor Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acticor Biotech SAS are associated (or correlated) with Rubis SCA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rubis SCA has no effect on the direction of Acticor Biotech i.e., Acticor Biotech and Rubis SCA go up and down completely randomly.

Pair Corralation between Acticor Biotech and Rubis SCA

Assuming the 90 days trading horizon Acticor Biotech SAS is expected to generate 6.31 times more return on investment than Rubis SCA. However, Acticor Biotech is 6.31 times more volatile than Rubis SCA. It trades about 0.03 of its potential returns per unit of risk. Rubis SCA is currently generating about -0.12 per unit of risk. If you would invest  42.00  in Acticor Biotech SAS on September 3, 2024 and sell it today you would lose (13.00) from holding Acticor Biotech SAS or give up 30.95% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Acticor Biotech SAS  vs.  Rubis SCA

Acticor Biotech SAS

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Acticor Biotech SAS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Acticor Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Rubis SCA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rubis SCA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Acticor Biotech and Rubis SCA

The main advantage of trading using opposite Acticor Biotech and Rubis SCA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acticor Biotech position performs unexpectedly, Rubis SCA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rubis SCA will offset losses from the drop in Rubis SCA's long position.

The idea behind Acticor Biotech SAS and Rubis SCA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.